Upgrade to SI Premium - Free Trial

Monopar Therapeutics (MNPR)

72.35 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/6/26)

Latest Headlines

Form 4 Monopar Therapeutics For: Oct 20 Filed by: Robinson Chandler October 20, 2026 4:59 PM - SEC Filing Form 4 Monopar Therapeutics For: Oct 01 Filed by: STARR CHRISTOPHER M October 5, 2026 5:43 PM - SEC Filing Form 4 Monopar Therapeutics For: Sep 30 Filed by: Cittadine Andrew October 2, 2026 6:15 PM - SEC Filing Form 4 Monopar Therapeutics For: Sep 30 Filed by: Robinson Chandler October 2, 2026 6:15 PM - SEC Filing Form 4 Monopar Therapeutics For: Sep 30 Filed by: Vu Quan Anh October 2, 2026 6:14 PM - SEC Filing Form 144 Monopar Therapeutics Filed by: STARR CHRISTOPHER M October 1, 2026 4:38 PM - SEC Filing Form 4 Monopar Therapeutics For: Sep 24 Filed by: Robinson Chandler September 28, 2026 8:48 PM - SEC Filing Form 144 Monopar Therapeutics Filed by: Robinson Chandler September 24, 2026 4:41 PM - SEC Filing Monopar Therapeutics (MNPR) PT Raised to $145 at Barclays September 11, 2026 5:29 AM - StreetInsider Form 4/A Monopar Therapeutics For: Aug 26 Filed by: Tsuchimoto Kim R August 28, 2026 8:18 PM - SEC Filing Form 4/A Monopar Therapeutics For: Aug 25 Filed by: Anderson Raymond August 28, 2026 7:41 PM - SEC Filing Form 4 Monopar Therapeutics For: Aug 26 Filed by: RIOUX PATRICE August 27, 2026 7:29 PM - SEC Filing Form 4 Monopar Therapeutics For: Aug 26 Filed by: Tsuchimoto Kim R August 27, 2026 6:29 PM - SEC Filing Form 4 Monopar Therapeutics For: Aug 25 Filed by: Anderson Raymond August 27, 2026 6:28 PM - SEC Filing Form 144 Monopar Therapeutics Filed by: RIOUX PATRICE August 26, 2026 4:20 PM - SEC Filing Form 144 Monopar Therapeutics Filed by: Tsuchimoto Kim R August 26, 2026 4:18 PM - SEC Filing Form 144 Monopar Therapeutics Filed by: Anderson Raymond August 25, 2026 4:45 PM - SEC Filing Monopar names medical affairs chief, gets two AASLD presentations August 19, 2026 8:00 AM - StreetInsider Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026 August 19, 2026 8:00 AM - StreetInsider Monopar Therapeutics (MNPR) PT Raised to $130 at Morgan Stanley August 17, 2026 8:58 AM - StreetInsider Monopar Therapeutics (MNPR) PT Raised to $128 at Barclays August 13, 2026 5:38 AM - StreetInsider Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral August 13, 2026 4:24 AM - StreetInsider Form SCHEDULE 13G/A Monopar Therapeutics Filed by: Saturn V Capital Management LP August 12, 2026 6:26 PM - SEC Filing Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG August 12, 2026 3:48 PM - StreetInsider Form SCHEDULE 13G/A Monopar Therapeutics Filed by: Adage Capital Management, L.P. August 12, 2026 12:05 PM - SEC Filing Form 8-K Monopar Therapeutics For: Aug 12 August 12, 2026 9:31 AM - SEC Filing Form 10-Q Monopar Therapeutics For: Jun 30 August 12, 2026 9:31 AM - SEC Filing Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates August 12, 2026 9:30 AM - StreetInsider Full Article List